Form D — IVIEW Therapeutics, Inc.
0001848749-25-000001 · filed Feb 24, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $15,000,000
- Reported amount sold
- $7,677,371
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- IVIEW Therapeutics, Inc.
- CIK
- 1848749
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 5 Cedar Brook Drive
Cranbury, NJ 08512 - Phone
- 6097738580
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Bo Liang · Executive OfficerCranbury, NJ Find on LinkedIn ↗
-
Qi Zhu · DirectorCranbury, NJ Find on LinkedIn ↗
-
Wei Wang · Executive OfficerCranbury, NJ Find on LinkedIn ↗
-
Houman Hemmati · Executive OfficerCranbury, NJ Find on LinkedIn ↗
-
Jingjie Li · DirectorCranbury, NJ Find on LinkedIn ↗
-
Bin He · DirectorCranbury, NJ Find on LinkedIn ↗
-
Xiaolu Sun · DirectorCranbury, NJ Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗